(i) Chloroquine and Hydroxychloroquine:
These are the anti-malarial drugs that have gained popularity after
research from China and France showed they improved patient outcomes.
However, Dr Mahmood from Agha Khan University said the study from China
on 100 COVID-19 cases was poorly designed while that of France was
open-labelled, non-randomized and only conducted on 36 patients.
According to some doctors in Pakistan these both are cardiotoxic, means
they damage heart by changing its rhythm (Ahmed, 2020).